HSV‐2 enhances ZIKV infection of the placenta and induces apoptosis in first‐trimester trophoblast cells

P Aldo, Y You, K Szigeti, TL Horvath… - American Journal of …, 2016 - Wiley Online Library
P Aldo, Y You, K Szigeti, TL Horvath, B Lindenbach, G Mor
American Journal of Reproductive Immunology, 2016Wiley Online Library
Problem Zika virus (ZIKV) has gained public concern for its association with microcephaly in
infants born to ZIKV‐infected mothers. To reach the fetus the virus must overcome the
defense mechanisms provided by trophoblast cells. Additionally, in the first trimester, the
integrity of the placenta is critical for fetal protection as damage to differentiating trophoblast
can affect placental formation and function. We sought to investigate the effect of ZIKV
infection on trophoblast cells and the factors that might increase the risk for ZIKV infection …
Problem
Zika virus (ZIKV) has gained public concern for its association with microcephaly in infants born to ZIKV‐infected mothers. To reach the fetus the virus must overcome the defense mechanisms provided by trophoblast cells. Additionally, in the first trimester, the integrity of the placenta is critical for fetal protection as damage to differentiating trophoblast can affect placental formation and function. We sought to investigate the effect of ZIKV infection on trophoblast cells and the factors that might increase the risk for ZIKV infection during pregnancy.
Methods
First‐trimester human trophoblast cells, Swan 7.1, were infected with ZIKV, herpes simplex virus‐2 (HSV‐2), and yellow fiver (YFV). C57BL/6 pregnant mice were infected with HSV‐2, ZIKV, or coinfection. Placental viral titers were determined by RT‐PCR.
Results
ZIKV infection induces apoptosis in first‐trimester trophoblasts and prevents differentiation of these cells. Furthermore, HSV‐2 infection enhances placental sensitivity to ZIKV by enhancing the expression of TAM receptors, which facilitate ZIKV cell entry.
Conclusion
These findings may explain the mechanism by which ZIKV breaches the placental barrier to access the fetus. Furthermore, our results suggest that patients with HSV‐2 infection are at a higher risk for the teratogenic effects induced by ZIKV.
Wiley Online Library